The Fifth Annual Ophthalmology Summit provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. WilmerHale Partner David Redlick was a featured speaker on the panel, “Going Public – Who, When, and Why?” at this event. Additional panelists include representatives from JP Morgan, Alimera Science, Clarus Ventures, Stephens, Inc. and Ophthotech.
View a video of the panel discussion.
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
